{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:10:56Z","timestamp":1782760256290,"version":"3.54.5"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72396-7","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:06:43Z","timestamp":1778576803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Whole-protein screening and multi-modal profiling of antigen-specific CD4+ T cells at single-cell resolution"],"prefix":"10.1038","volume":"17","author":[{"given":"Rongyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"McKasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0394-9978","authenticated-orcid":false,"given":"Jongchan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4412-2811","authenticated-orcid":false,"given":"Sunga","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1817-0123","authenticated-orcid":false,"given":"William","family":"Chour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3692-8524","authenticated-orcid":false,"given":"Rachel H.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simranjeet K.","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6660-6257","authenticated-orcid":false,"given":"Daniel","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Edmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Rowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yapeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie R.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3992-9143","authenticated-orcid":false,"given":"Jia Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Nawaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Duven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2803-4152","authenticated-orcid":false,"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6457-6023","authenticated-orcid":false,"given":"Mihae","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8136-2112","authenticated-orcid":false,"given":"Saul J.","family":"Priceman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4915-8207","authenticated-orcid":false,"given":"Christine E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3669-8458","authenticated-orcid":false,"given":"Antoni","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly G.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"Drescher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3014-3649","authenticated-orcid":false,"given":"Cristina","family":"Puig-Saus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3825-6832","authenticated-orcid":false,"given":"Jason D.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0397-5295","authenticated-orcid":false,"given":"Cornelia L.","family":"Trimble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-4385","authenticated-orcid":false,"given":"James R.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"72396_CR1","doi-asserted-by":"publisher","first-page":"925135","DOI":"10.1155\/2012\/925135","volume":"2012","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram, R. V., Zhou, R., Verma, A. D. & Xia, B. CD4+T cells: differentiation and functions. Clin. Dev. Immunol. 2012, 925135 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"72396_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41417-020-0183-x","volume":"28","author":"RE Tay","year":"2021","unstructured":"Tay, R. E., Richardson, E. K. & Toh, H. C. Revisiting the role of CD4+ T cells in cancer immunotherapy\u2014new insights into old paradigms. Cancer Gene Ther. 28, 5\u201317 (2021).","journal-title":"Cancer Gene Ther."},{"key":"72396_CR3","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.immuni.2021.11.015","volume":"54","author":"DY Oh","year":"2021","unstructured":"Oh, D. Y. & Fong, L. Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox. Immunity 54, 2701\u20132711 (2021).","journal-title":"Immunity"},{"key":"72396_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22811-y","volume":"12","author":"A Gangaev","year":"2021","unstructured":"Gangaev, A. et al. Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features. Nat. Commun. 12, 2593 (2021).","journal-title":"Nat. Commun."},{"key":"72396_CR5","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/nbt.3662","volume":"34","author":"AK Bentzen","year":"2016","unstructured":"Bentzen, A. K. et al. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat. Biotechnol. 34, 1037\u20131045 (2016).","journal-title":"Nat. Biotechnol."},{"key":"72396_CR6","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/s41590-021-01073-2","volume":"22","author":"K-Y Ma","year":"2021","unstructured":"Ma, K.-Y. et al. High-throughput and high-dimensional single-cell analysis of antigen-specific CD8+ T cells. Nat. Immunol. 22, 1590\u20131598 (2021).","journal-title":"Nat. Immunol."},{"key":"72396_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-023-04899-8","volume":"6","author":"W Chour","year":"2023","unstructured":"Chour, W. et al. Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis. Commun. Biol. 6, 1\u201313 (2023).","journal-title":"Commun. Biol."},{"key":"72396_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41586-023-05787-1","volume":"615","author":"C Puig-Saus","year":"2023","unstructured":"Puig-Saus, C. et al. Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy. Nature 615, 697\u2013704 (2023).","journal-title":"Nature"},{"key":"72396_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41586-022-05531-1","volume":"615","author":"SP Foy","year":"2023","unstructured":"Foy, S. P. et al. Non-viral precision T cell receptor replacement for personalized cell therapy. Nature 615, 687\u2013696 (2023).","journal-title":"Nature"},{"key":"72396_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56659-3","volume":"16","author":"J Xie","year":"2025","unstructured":"Xie, J. et al. APMAT analysis reveals the association between CD8 T cell receptors, cognate antigen, and T cell phenotype and persistence. Nat. Commun. 16, 1402 (2025).","journal-title":"Nat. Commun."},{"key":"72396_CR11","doi-asserted-by":"crossref","unstructured":"Moravec, Z. et al. Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening. Nat. Biotechnol. 43, 214\u2013222 (2024).","DOI":"10.1038\/s41587-024-02210-6"},{"key":"72396_CR12","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/nm1292","volume":"11","author":"M Frentsch","year":"2005","unstructured":"Frentsch, M. et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat. Med. 11, 1118\u20131124 (2005).","journal-title":"Nat. Med."},{"key":"72396_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/imcb.12636","volume":"101","author":"C Poloni","year":"2023","unstructured":"Poloni, C. et al. T-cell activation\u2013induced marker assays in health and disease. Immunol. Cell Biol. 101, 491\u2013503 (2023).","journal-title":"Immunol. Cell Biol."},{"key":"72396_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","volume":"584","author":"N Le Bert","year":"2020","unstructured":"Le Bert, N. et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 584, 457\u2013462 (2020).","journal-title":"Nature"},{"key":"72396_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12614","volume":"7","author":"H Uchtenhagen","year":"2016","unstructured":"Uchtenhagen, H. et al. Efficient ex vivo analysis of CD4+ T-cell responses using combinatorial HLA class II tetramer staining. Nat. Commun. 7, 12614 (2016).","journal-title":"Nat. Commun."},{"key":"72396_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/369151a0","volume":"369","author":"H Kozono","year":"1994","unstructured":"Kozono, H., White, J., Clements, J., Marrack, P. & Kappler, J. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369, 151\u2013154 (1994).","journal-title":"Nature"},{"key":"72396_CR17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1172\/JCI200318509","volume":"112","author":"CL Day","year":"2003","unstructured":"Day, C. L. et al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Invest. 112, 831\u2013842 (2003).","journal-title":"J. Clin. Invest."},{"key":"72396_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.immuni.2007.07.007","volume":"27","author":"JJ Moon","year":"2007","unstructured":"Moon, J. J. et al. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27, 203\u2013213 (2007).","journal-title":"Immunity"},{"key":"72396_CR19","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.4049\/jimmunol.175.10.6334","volume":"175","author":"TJ Scriba","year":"2005","unstructured":"Scriba, T. J. et al. Ultrasensitive detection and phenotyping of CD4+ T cells with optimized HLA class II tetramer staining. J. Immunol. 175, 6334\u20136343 (2005).","journal-title":"J. Immunol."},{"key":"72396_CR20","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.4049\/jimmunol.1102190","volume":"188","author":"WW Kwok","year":"2012","unstructured":"Kwok, W. W. et al. Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire. J. Immunol. 188, 2537\u20132544 (2012).","journal-title":"J. Immunol."},{"key":"72396_CR21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41591-019-0403-9","volume":"25","author":"A Christophersen","year":"2019","unstructured":"Christophersen, A. et al. Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions. Nat. Med. 25, 734\u2013737 (2019).","journal-title":"Nat. Med."},{"key":"72396_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2022.100388","volume":"3","author":"R Vyasamneni","year":"2023","unstructured":"Vyasamneni, R. et al. A universal MHCII technology platform to characterize antigen-specific CD4+ T cells. Cell Rep. Methods 3, 100388 (2023).","journal-title":"Cell Rep. Methods"},{"key":"72396_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0161-5890(03)00010-5","volume":"39","author":"WP Thayer","year":"2003","unstructured":"Thayer, W. P., Dao, C. T., Ignatowicz, L. & Jensen, P. E. A novel single chain I-Ab molecule can stimulate and stain antigen-specific T cells. Mol. Immunol. 39, 861\u2013870 (2003).","journal-title":"Mol. Immunol."},{"key":"72396_CR24","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen, X., Zaro, J. L. & Shen, W.-C. Fusion protein linkers: property, design and functionality. Adv. Drug Deliv. Rev. 65, 1357\u20131369 (2013).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"72396_CR25","first-page":"D783","volume":"48","author":"FF Gonzalez-Galarza","year":"2020","unstructured":"Gonzalez-Galarza, F. F. et al. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res. 48, D783\u2013D788 (2020).","journal-title":"Nucleic Acids Res."},{"key":"72396_CR26","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.humimm.2007.04.005","volume":"68","author":"M Maiers","year":"2007","unstructured":"Maiers, M., Gragert, L. & Klitz, W. High-resolution HLA alleles and haplotypes in the United States population. Hum. Immunol. 68, 779\u2013788 (2007).","journal-title":"Hum. Immunol."},{"key":"72396_CR27","doi-asserted-by":"publisher","first-page":"14960","DOI":"10.1073\/pnas.1207186109","volume":"109","author":"L Deng","year":"2012","unstructured":"Deng, L., Langley, R. J., Wang, Q., Topalian, S. L. & Mariuzza, R. A. Structural insights into the editing of germ-line\u2013encoded interactions between T-cell receptor and MHC class II by V\u03b1 CDR3. Proc. Natl. Acad. Sci. USA 109, 14960\u201314965 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72396_CR28","doi-asserted-by":"publisher","first-page":"eaat0687","DOI":"10.1126\/sciimmunol.aat0687","volume":"3","author":"M Galperin","year":"2018","unstructured":"Galperin, M. et al. CD4+ T cell\u2013mediated HLA class II cross-restriction in HIV controllers. Sci. Immunol. 3, eaat0687 (2018).","journal-title":"Sci. Immunol."},{"key":"72396_CR29","doi-asserted-by":"crossref","unstructured":"Benati, D. et al. Public T cell receptors confer high-avidity CD4 responses to HIV controllers. J. Clin. Invest. 126, 2093\u20132108 (2016).","DOI":"10.1172\/JCI83792"},{"key":"72396_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41591-020-01206-4","volume":"27","author":"Z Hu","year":"2021","unstructured":"Hu, Z. et al. Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma. Nat. Med. 27, 515\u2013525 (2021).","journal-title":"Nat. Med."},{"key":"72396_CR31","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.immuni.2023.03.020","volume":"56","author":"L Ciacchi","year":"2023","unstructured":"Ciacchi, L. et al. CD4+ T cell-mediated recognition of a conserved cholesterol-dependent cytolysin epitope generates broad antibacterial immunity. Immunity 56, 1082\u20131097.e6 (2023).","journal-title":"Immunity"},{"key":"72396_CR32","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S0969-2126(97)00288-8","volume":"5","author":"VL Murthy","year":"1997","unstructured":"Murthy, V. L. & Stern, L. J. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. Structure 5, 1385\u20131396 (1997).","journal-title":"Structure"},{"key":"72396_CR33","doi-asserted-by":"publisher","first-page":"13258","DOI":"10.1073\/pnas.1006344107","volume":"107","author":"W Jiang","year":"2010","unstructured":"Jiang, W. & Boder, E. T. High-throughput engineering and analysis of peptide binding to class II MHC. Proc. Natl. Acad. Sci. USA 107, 13258\u201313263 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72396_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature22976","volume":"547","author":"J Glanville","year":"2017","unstructured":"Glanville, J. et al. Identifying specificity groups in the T cell receptor repertoire. Nature 547, 94\u201398 (2017).","journal-title":"Nature"},{"key":"72396_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep31580","volume":"6","author":"S Rosskopf","year":"2016","unstructured":"Rosskopf, S. et al. Creation of an engineered APC system to explore and optimize the presentation of immunodominant peptides of major allergens. Sci. Rep. 6, 31580 (2016).","journal-title":"Sci. Rep."},{"key":"72396_CR36","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41587-020-0505-4","volume":"38","author":"H Huang","year":"2020","unstructured":"Huang, H., Wang, C., Rubelt, F., Scriba, T. J. & Davis, M. M. Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat. Biotechnol. 38, 1194\u20131202 (2020).","journal-title":"Nat. Biotechnol."},{"key":"72396_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","volume":"584","author":"B Ju","year":"2020","unstructured":"Ju, B. et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584, 115\u2013119 (2020).","journal-title":"Nature"},{"key":"72396_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","volume":"597","author":"TN Starr","year":"2021","unstructured":"Starr, T. N. et al. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature 597, 97\u2013102 (2021).","journal-title":"Nature"},{"key":"72396_CR39","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.cell.2021.02.035","volume":"184","author":"E Andreano","year":"2021","unstructured":"Andreano, E. et al. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell 184, 1821\u20131835.e16 (2021).","journal-title":"Cell"},{"key":"72396_CR40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.abc5902","volume":"369","author":"PJM Brouwer","year":"2020","unstructured":"Brouwer, P. J. M. et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science 369, 643\u2013650 (2020).","journal-title":"Science"},{"key":"72396_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290\u2013295 (2020).","journal-title":"Nature"},{"key":"72396_CR42","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21, 1336\u20131345 (2020).","journal-title":"Nat. Immunol."},{"key":"72396_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.abd3871","volume":"370","author":"J Mateus","year":"2020","unstructured":"Mateus, J. et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science 370, 89\u201394 (2020).","journal-title":"Science"},{"key":"72396_CR44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","volume":"22","author":"A Nelde","year":"2021","unstructured":"Nelde, A. et al. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nat. Immunol. 22, 74\u201385 (2021).","journal-title":"Nat. Immunol."},{"key":"72396_CR45","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cell.2020.09.015","volume":"183","author":"DK Wells","year":"2020","unstructured":"Wells, D. K. et al. Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction. Cell 183, 818\u2013834.e13 (2020).","journal-title":"Cell"},{"key":"72396_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12464-3","volume":"10","author":"PA Szabo","year":"2019","unstructured":"Szabo, P. A. et al. Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease. Nat. Commun. 10, 4706 (2019).","journal-title":"Nat. Commun."},{"key":"72396_CR47","doi-asserted-by":"crossref","unstructured":"Zhang, W. et al. CMV status drives distinct trajectories of CD4+ T cell differentiation. Front. Immunol. 12, 620386 (2021).","DOI":"10.3389\/fimmu.2021.620386"},{"key":"72396_CR48","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.cell.2020.10.037","volume":"183","author":"Y Su","year":"2020","unstructured":"Su, Y. et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183, 1479\u20131495.e20 (2020).","journal-title":"Cell"},{"key":"72396_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23324-4","volume":"12","author":"M Andreatta","year":"2021","unstructured":"Andreatta, M. et al. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat. Commun. 12, 2965 (2021).","journal-title":"Nat. Commun."},{"key":"72396_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/cancers8030036","volume":"8","author":"V Golubovskaya","year":"2016","unstructured":"Golubovskaya, V. & Wu, L. Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy. Cancers 8, 36 (2016).","journal-title":"Cancers"},{"key":"72396_CR51","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/imcb.12272","volume":"97","author":"MS Soon","year":"2019","unstructured":"Soon, M. S., Engel, J. A., Lee, H. J. & Haque, A. Development of circulating CD4+ T-cell memory. Immunol. Cell Biol. 97, 617\u2013624 (2019).","journal-title":"Immunol. Cell Biol."},{"key":"72396_CR52","doi-asserted-by":"crossref","unstructured":"Takeuchi, A. & Saito, T. CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function. Front. Immunol. 8, 194 (2017).","DOI":"10.3389\/fimmu.2017.00194"},{"key":"72396_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrc1802","volume":"6","author":"ML Whitfield","year":"2006","unstructured":"Whitfield, M. L., George, L. K., Grant, G. D. & Perou, C. M. Common markers of proliferation. Nat. Rev. Cancer 6, 99\u2013106 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"72396_CR54","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature06672","volume":"452","author":"LE Harrington","year":"2008","unstructured":"Harrington, L. E., Janowski, K. M., Oliver, J. R., Zajac, A. J. & Weaver, C. T. Memory CD4 T cells emerge from effector T-cell progenitors. Nature 452, 356\u2013360 (2008).","journal-title":"Nature"},{"key":"72396_CR55","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","volume":"591","author":"C Gaebler","year":"2021","unstructured":"Gaebler, C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639\u2013644 (2021).","journal-title":"Nature"},{"key":"72396_CR56","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.cmi.2024.09.001","volume":"30","author":"Z Swank","year":"2024","unstructured":"Swank, Z. et al. Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study. Clin. Microbiol. Infect. 30, 1599\u20131605 (2024).","journal-title":"Clin. Microbiol. Infect."},{"key":"72396_CR57","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881\u2013895.e20 (2022).","journal-title":"Cell"},{"key":"72396_CR58","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S1470-2045(09)70227-X","volume":"10","author":"CL Trimble","year":"2009","unstructured":"Trimble, C. L. & Frazer, I. H. Development of therapeutic HPV vaccines. Lancet Oncol. 10, 975\u2013980 (2009).","journal-title":"Lancet Oncol."},{"key":"72396_CR59","doi-asserted-by":"publisher","first-page":"348","DOI":"10.6004\/jnccn.2013.0044","volume":"11","author":"L Ramondetta","year":"2013","unstructured":"Ramondetta, L. What is the appropriate approach to treating women with incurable cervical cancer? J. Natl. Compr. Canc. Netw. 11, 348\u2013355 (2013).","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"72396_CR60","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1200\/JCO.18.02424","volume":"37","author":"SL Doran","year":"2019","unstructured":"Doran, S. L. et al. T-cell receptor gene therapy for human papillomavirus\u2013associated epithelial cancers: a first-in-human, phase I\/II study. J. Clin. Oncol. 37, 2759\u20132768 (2019).","journal-title":"J. Clin. Oncol."},{"key":"72396_CR61","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41591-020-01225-1","volume":"27","author":"NB Nagarsheth","year":"2021","unstructured":"Nagarsheth, N. B. et al. TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers. Nat. Med. 27, 419\u2013425 (2021).","journal-title":"Nat. Med."},{"key":"72396_CR62","doi-asserted-by":"publisher","first-page":"13279","DOI":"10.1073\/pnas.0403371101","volume":"101","author":"Z Zavala-Ruiz","year":"2004","unstructured":"Zavala-Ruiz, Z., Strug, I., Walker, B. D., Norris, P. J. & Stern, L. J. A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition. Proc. Natl. Acad. Sci. USA 101, 13279\u201313284 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72396_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1665","volume":"3","author":"DK Cole","year":"2012","unstructured":"Cole, D. K. et al. Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4+ T-cell repertoire selection. Nat. Commun. 3, 665 (2012).","journal-title":"Nat. Commun."},{"key":"72396_CR64","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4049\/jimmunol.169.2.739","volume":"169","author":"PY Arnold","year":"2002","unstructured":"Arnold, P. Y. et al. The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues1. J. Immunol. 169, 739\u2013749 (2002).","journal-title":"J. Immunol."},{"key":"72396_CR65","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.cell.2018.06.017","volume":"174","author":"LV Sibener","year":"2018","unstructured":"Sibener, L. V. et al. Isolation of a structural mechanism for uncoupling T cell receptor signaling from peptide-MHC binding. Cell 174, 672\u2013687.e27 (2018).","journal-title":"Cell"},{"key":"72396_CR66","doi-asserted-by":"publisher","first-page":"221ra13","DOI":"10.1126\/scitranslmed.3007323","volume":"6","author":"L Maldonado","year":"2014","unstructured":"Maldonado, L. et al. Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions. Sci. Transl. Med. 6, 221ra13 (2014).","journal-title":"Sci. Transl. Med."},{"key":"72396_CR67","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41592-022-01578-0","volume":"19","author":"M Goncharov","year":"2022","unstructured":"Goncharov, M. et al. VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2. Nat. Methods 19, 1017\u20131019 (2022).","journal-title":"Nat. Methods"},{"key":"72396_CR68","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S1074-7613(00)80250-2","volume":"4","author":"DB Sant\u2019Angelo","year":"1996","unstructured":"Sant\u2019Angelo, D. B. et al. The specificity and orientation of a TCR to its peptide\u2013MHC class II ligands. Immunity 4, 367\u2013376 (1996).","journal-title":"Immunity"},{"key":"72396_CR69","doi-asserted-by":"publisher","unstructured":"Fornace, M. E. et al. NUPACK: analysis and design of nucleic acid structures, devices, and systems. Preprint at ChemRxiv https:\/\/doi.org\/10.26434\/chemrxiv-2022-xv98l (2022).","DOI":"10.26434\/chemrxiv-2022-xv98l"},{"key":"72396_CR70","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1038\/s41598-018-22931-4","volume":"8","author":"M Anczurowski","year":"2018","unstructured":"Anczurowski, M. et al. Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP84. Gly. Sci. Rep. 8, 4804 (2018).","journal-title":"Gly. Sci. Rep."},{"key":"72396_CR71","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1021\/acs.jproteome.9b00874","volume":"19","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B. et al. Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data. J. Proteome Res. 19, 2304\u20132315 (2020).","journal-title":"J. Proteome Res."},{"key":"72396_CR72","doi-asserted-by":"crossref","unstructured":"Xie, J. & Heath, J. 1539 SARS-CoV-2 genome-wide single-chain-trimer peptide-MHCs reveal CD8+ T cell landscape in COVID-19 patients and distinct TCR repertoire dynamics. J. Immunother. Cancer 11, eabf7550 (2023).","DOI":"10.1136\/jitc-2023-SITC2023.1539"},{"key":"72396_CR73","doi-asserted-by":"publisher","unstructured":"Poplin, R. et al. Scaling accurate genetic variant discovery to tens of thousands of samples. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/201178 (2018).","DOI":"10.1101\/201178"},{"key":"72396_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1865-2","volume":"20","author":"Y Huang","year":"2019","unstructured":"Huang, Y., McCarthy, D. J. & Stegle, O. Vireo: Bayesian demultiplexing of pooled single-cell RNA-seq data without genotype reference. Genome Biol. 20, 273 (2019).","journal-title":"Genome Biol."},{"key":"72396_CR75","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.immuni.2023.03.009","volume":"56","author":"J Racle","year":"2023","unstructured":"Racle, J. et al. Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes. Immunity 56, 1359\u20131375.e13 (2023).","journal-title":"Immunity"},{"key":"72396_CR76","unstructured":"Zhang, R. https:\/\/BioRender.com\/v67dds1 (2026)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72396-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72396-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72396-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:06:57Z","timestamp":1778576817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72396-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72396"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72396-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.P.-S. has received honoraria from Merck, Kyowa Kirin, and ImmPACT Bio. J.D.G. has consulted for Gilead, Merck, Ivivyd, obtained grants from Gilead and has contracted research with Gilead and Helix. J.R.H. is a consultant to Regeneron and has received research support from Gilead and Merck. A.R. has received honoraria from consulting with Amgen and Merck, is or has been a member of the scientific advisory board and holds stock in Appia, Apricity, Arcus, Compugen, CytomX, ImaginAb, ImmPact, Inspirna, Kite-Gilead, Larkspur, Lyell, Lutris, MapKure, Merus, Synthekine, and Tango, has received research funding from Agilent and from Bristol Myers Squibb through Stand Up to Cancer (SU2C), and patent royalties from Arsenal Bio. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3979"}}